An interventional study of Multicomponent Physical Activity Program and Mindfulness-Based Stress Reduction Program in Stroke, sponsored by University of Barcelona. Completed at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-03-02.
Sponsored by University of Barcelona · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 323 studies in Stroke with a site in Spain — 73 open to participants now, 91 under way, 6 of them phase 3. Stroke · Spain.
Among the 323 studies in Stroke with a site in Spain, this one is the 92nd largest by enrollment of the 246 interventional ones that give a count, is one of 21 that started in 2020, is one of 159 with no phase, and was the 186th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →73 of the 323 studies in Stroke with a site in Spain are open now. Recruiting first, the newest first:
Neuron, Spain · Sites in Spain
Ages 18+ · Healthy volunteers
Hospital Universitari Vall d'Hebron Research Institute · Sites in Spain
Ages 18–80
Hospital Universitari Vall d'Hebron Research Institute · Sites in Spain, Belgium, Germany and 3 more countries
Ages 18+
Ancor Rebassa Cabrera · Sites in Spain
Ages 18+
Dr. Yaroslav Winter · Sites in Spain, Czechia, Germany and 1 more country
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
323 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 21 · Phase 3 44 · Phase 4 21
First in 1998; this study’s year is marked. 21 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 141 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 70 across the 246 interventional studies, 250 across the 77 observational. Of the 197 that completed or were terminated, 33 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
83 of 323 have an industry lead sponsor. The 10 most frequent:
University of Barcelona is the lead sponsor of 100 studies on the registry; 30 are open to participants now.
University of Barcelona has 3 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
24 of the studies in Stroke with a site in Spain that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05065216Phase 3DiaMedica Therapeutics IncTreatment of Acute Ischemic Stroke (ReMEDy2 Trial) | 2026-12 |
| NCT06296082Phase 3Universiteit AntwerpenComparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity | 2026-12-30 |
| NCT05691244Phase 3Pharmazz, Inc.Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | 2027-09 |
| NCT07357285iVascular S.L.U.Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO) | 2026-11 |
| NCT07497464Alfredo Lerín CalvoValidity of an Open-access Handedness Recognition Task in Stroke Patients | 2026-11 |
Add all 24 to your calendar (.ics) → With an account.
Among the 323 studies in Stroke with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main objective of MindFit Project is to develop an evidence-based multimodal investigation of combined non-pharmacological strategies in chronic stroke patients and clarify the neuroplasticity mechanisms underlying the benefits of physical exercise and mindfulness strategies combined with cognitive training on post-stroke recovery. The investigators have adopted a multidisciplinary and multimodal approach to provide a more integrative perspective using cognitive, social-psychological, biochemical, and neuroimaging measurements.
The MindFit Project is a multicentric, prospective, parallel, single-blinded, randomized controlled trial with a sample of 141 participants at 3 to 60 months after stroke. Participants are randomly allocated to one of three arms (through a simple randomizing procedure with a 1:1:1 ratio created with a random sequence generator software).
The first group (n=47) receives computer-based cognitive training (CCT) combined with a multicomponent physical exercise program. The second group (n=47) receives CCT combined with mindfulness-based stress reduction therapy. Finally, the third group (n=47), as an active control group, receives only CCT. All interventions last 12 weeks.
Within two weeks before the start of the interventions, and again at 3 months after completing the interventions, medical, cognitive, and physical assessments, neuroimaging, and biological samples collection are performed.
The objectives of this project are:
Inclusion Criteria:
Exclusion Criteria:
Exclusion criteria only for MRI examination:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The Physical exercise \& cognitive training group receives a multicomponent physical exercise program combined with computer-based cognitive training.
Behavioral: Multicomponent Physical Activity Program · Behavioral: Computerized Cognitive Training
The Mindfulness \& cognitive training group receives mindfulness-based stress reduction therapy combined with computer-based cognitive training.
Behavioral: Mindfulness-Based Stress Reduction Program · Behavioral: Computerized Cognitive Training
The Cognitive training group, as an active control group, receives only computer-based cognitive training.
Behavioral: Computerized Cognitive Training
The proposed physical exercise intervention follows the American College of Sports Medicine (ACSM, 2017) and the American Stroke Association (Billinger et al., 2014) recommendations for stroke patients. The five weekly 45-minute sessions are divided into (1) three sessions guided and supervised telematically by a physical exercise specialist and a physiotherapist; (2) and two autonomous exercise sessions. The supervised sessions include exercises to work aerobic capacity, muscle strength and endurance, flexibility, agility, and balance. The intensity of these exercises is prescribed individually according to each participant's initial level and are gradually increased as the program progresses. Participants are encouraged to walk at a similar intensity on autonomous physical exercise days as performed in the guided sessions (moderate intensity), based on the Borg scale of perceived exertion (Borg, 1982).
This intervention follows an adaptation of the scheme and instructions of the official Mindfulness-Based Stress Reduction (MBSR) program designed by Jon Kabat-Zinn. It includes body scanning, sitting meditation, and gentle hatha yoga techniques. An accredited mindfulness instructor leads the 12-week online program, which comprises a presentation session, followed by eight intervention sessions (once a week, lasting 2.5 hours) and an intensive practice session interspersed between sessions six and seven. Apart from the supervised session, the therapist asks participants to carry out some independent practice daily.
An accredited neuropsychologist programs and supervises the computerized cognitive training through the Guttmann Neuropersonal Trainer (GNPT®) platform. The 12-week program consists of five sessions a week (45 minutes each) that include personalized activities planned to stimulate executive functioning, attention, processing speed, and memory.
Change in immediate verbal attention after receiving treatment
Forward Digit Span (WAIS III)
Time frame: 3 months (at baseline, 3 months from baseline)
Change in verbal digit working memory after receiving treatment
Backward Digit Span (WAIS III)
Time frame: 3 months (at baseline, 3 months from baseline)
Change in verbal memory after receiving treatment
Rey Auditory Learning Test
Time frame: 3 months (at baseline, 3 months from baseline)
Change in visual memory after receiving treatment
Rey's Complex Figure Test
Time frame: 3 months (at baseline, 3 months from baseline)
Change in executive function, verbal fluency after receiving treatment
Phonetic Fluency is measured using the Controlled Oral Word Association Test, spanish adaptation, and semantic fluency test using the category Animal
Time frame: 3 months (at baseline, 3 months from baseline)
Change in executive function, inhibition after receiving treatment
Stroop Test
Time frame: 3 months (at baseline, 3 months from baseline)
Change in executive function, set-switching task after receiving treatment
Trail Making Test
Time frame: 3 months (at baseline, 3 months from baseline)
Change in language, naming after receiving treatment
Boston naming Test
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in psychological distress
Clinical Outcomes in Routine Evaluation (CORE-OM)
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in depression and anxiety
Depression Anxiety Stress Scale (DASS-21)
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in wellbeing
Ryff Scales of Psychological Wellbeing.
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in Mindfulness
Mindful Attention Awareness Scale (MAAS)
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in White matter integrity
White matter integrity: tractography
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in Resting-state connectivity
Resting state brain activity using fMRI
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in brain volumetry
Grey and white matter volume measured by MRI
Time frame: 3 months (at baseline, 3 months from baseline)
Molecular changes: growth factors (BDNF, SDF1-a, VEGF-A, IGF-1, and NGF), cortisol, protein C reactive, IL-6 and homocysteine levels
Quantification of different biomarkers from blood samples.
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in Microbiota data
Bacterial composition of stool samples in terms of relative abundance
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in Sleep
Pittsburgh Sleep Quality Index (PSQI)
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in Fitness
Senior Fitness Test (SFT)
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in stroke specific quality of life
Stroke-specific Quality of Life Scale (ECVI-38)
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in quality of life
World Health Organization Quality of Life (WHOQOL-BREF)
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in mental fatigue
Fatigue Assessment Scale (FAS)
Time frame: 3 months (at baseline, 3 months from baseline)
Changes in physical activity:
Spanish version of the reduced Minnesota leisure-time physical and activity questionnaire (VREM)
Time frame: 3 months (at baseline, 3 months from baseline)
Plan to share: No
Ran from Oct 2020 to primary completion in Jul 2021, 9 months.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 9 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.